Report
EUR 18.48 For Business Accounts Only

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Underlying
Crown Bioscience International

CROWN BIOSCIENCE INTERNATIONAL is a Taiwan-based company mainly engaged in providing translational research platform and efficient drug discovery solutions. The Company focuses on the treatment of cancer and metabolic diseases preclinical drug research, and providing new drug efficacy evaluation platform for pharmaceutical manufactures and biotechnology companies. It main products and services include cell biology, proteins study, cell source tumor animal models, anthropogenic tumor animal models, among others.

Provider
Ford Equity Research
Ford Equity Research

Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.

Other Reports on these Companies

クラウン・バイオサイエンス、革新的なバーチャル形式でのAACR 2020会議・展示会を開催

クラウン・バイオサイエンス、革新的なバーチャル形式でのAACR 2020会議・展示会を開催 バーチャルAACRイベントで、新しいがんおよびがん免疫療法の臨床前研究を発表 サンディエゴ発, June 19, 2020 (GLOBE NEWSWIRE) -- クラウン・バイオサイエンス (Crown Bioscience) は本日、革新的なAACR 2020会議・展示会を発表した。6月22日から25日まで開催されるこのバーチャルイベントには、基調講演、クラウンバイオのAACR 2020ポスターセッション、展示会ブースなど、主要な科学会議のすべての機能が組み込まれる。 米国がん学会 (AACR) バーチャル年次総会の第二部と合わせて行われる、このユニークなフォーラムでは、クラウンバイオの内部研究および共同研究計13件をAACR 2020でポスター発表する。その内容は、腫瘍オルガノイドおよびオルガノイド工学や、自家移植、腫瘍の同種移植の画像化、新しいヒト化薬剤標的モデルなど、前臨床がん研究およびがん免疫療法に関するさまざまなトピックを網羅している。そしてポスター発表者が出席してすべての代表者の質問に答える。 このイベントには無料で、参加可能で登録はこちらから: 基調講演配信のハイライトは、クラウンバイオの最高科学責任者であるヘンリー・リー (Henry Li...

Other Reports from Ford Equity Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch